Literature DB >> 832473

Mechanisms of acquired resistance to Pasteurella multocida infection: a review.

F M Collins.   

Abstract

Pasteurella multocida is an animal parasite of considerable economic and veterinary importance. The organism produces both capsular polysaccharide and somatic (lipopolysaccharide) antigens used to serotype the organisms. Correlations exist between antigenic structure, host susceptibility and strain virulence. The host response seems to be predominantly polymorphonuclear in nature, with little evidence of a mononuclear component in the host response to infection. In the absence of specific opsonins, phagocytosis rates are very slow, the organisms multiplying freely in an essentially extracellular environment. Passive transfer studies indicate that acquired resistance is humorally modiated, presumably by promoting phagocytosis withing the peritoneal cavity. There is, however, no sign of early increased local bactericidal action within the peritoneal cavity; protection seems rather to be due to an inhibition of the rapid spread by the organisms to the bloodstream and other reticuloendothelial organs. Viable attenuated oral vaccines are effective for chicken and turkey poults, both experimentally and under field conditions. The nature of the protective immunoglobulins and their mode of action against an orally induced infection has not been widely examined as yet. Effective protection can be achieved in birds, cattle and experimental animals with a variety of killed vaccines (especially when presented in a suitable adjuvant). The lack of quantitative growth data in suitably vaccinated animals and the absence of definitive studies of the bactericidal mechanisms involved in the expression of this acquired resistance continue to limit our present understanding of defense against this important animal disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 832473

Source DB:  PubMed          Journal:  Cornell Vet        ISSN: 0010-8901


  14 in total

1.  An outbreak of haemorrhagic septicaemia (septicaemic pasteurellosis) in cattle in Zimbabwe.

Authors:  E P Lane; N D Kock; F W Hill; K Mohan
Journal:  Trop Anim Health Prod       Date:  1992-05       Impact factor: 1.559

2.  The first case of Pasteurella canis bacteremia: a cirrhotic patient with an open leg wound.

Authors:  T J Albert; D L Stevens
Journal:  Infection       Date:  2010-07-10       Impact factor: 3.553

3.  Effect of type A Pasteurella multocida fractions on bovine polymorphonuclear leukocyte functions.

Authors:  H Ryu; M L Kaeberle; J A Roth; R W Griffith
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

4.  A unique outbreak of Pasteurella multocida in a chronic disease hospital.

Authors:  M Itoh; P M Tierno; M Milstoc; A R Berger
Journal:  Am J Public Health       Date:  1980-11       Impact factor: 9.308

5.  Microorganisms associated with pneumonia in slaughter weight swine.

Authors:  R B Morrison; C Pijoan; H D Hilley; V Rapp
Journal:  Can J Comp Med       Date:  1985-04

6.  Adhesion of type A Pasteurella mulocida to rabbit pharyngeal cells and its possible role in rabbit respiratory tract infections.

Authors:  J C Glorioso; G W Jones; H G Rush; L J Pentler; C A Darif; J E Coward
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

Review 7.  A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle.

Authors:  W D Yates
Journal:  Can J Comp Med       Date:  1982-07

8.  Protection of rabbits against experimental pasteurellosis by a streptomycin-dependent Pasteurella multocida serotype 3:A live mutant vaccine.

Authors:  Y S Lu; S P Pakes
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

Review 9.  Liposomes in treatment of infectious diseases.

Authors:  F Emmen; G Storm
Journal:  Pharm Weekbl Sci       Date:  1987-06-19

10.  Vaccination studies against experimental bovine Pasteurella pneumonia.

Authors:  M A Cardella; M A Adviento; R M Nervig
Journal:  Can J Vet Res       Date:  1987-04       Impact factor: 1.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.